The Staging of High-risk And non-metastatic Renal cell carcinoma Preoperatively (SHARP) Model predicts pathologic T3 stage for neoadjuvant clinical trial enrollment

Posted by author-avatar

Publication date: May 2026

Source: Urology, Volume 211

Author(s): Paz Lotan, Andrew L. Wentland, Daniel D. Shapiro, Matthew R. Smith, Daniel F. Roadman, Glenn O. Allen, David F. Jarrard, Kye Nichols, Michael C. Risk, Kyle A. Richards, Elizabeth L. Koehne, E. Jason Abel

Read More

Newer
Editorial Comment on “Trends of Motor-Vehicle Related Genitourinary Trauma as Compared to Motor Vehicle Fatalities from 2012 to 2022”
Older Preliminary Use of Indocyanine Green Fluorescence Angiography in Predicting the Blood Perfusion of Neourethra Covering in TIP Hypospadias Repair